Temozolomide compounds, polymers prepared therefrom, and method of treating a disease

US10562901B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10562901-B2
Application numberUS-201715709862-A
CountryUS
Kind codeB2
Filing dateSep 20, 2017
Priority dateSep 22, 2016
Publication dateFeb 18, 2020
Grant dateFeb 18, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A temozolomide compound according to formula (I) is described, wherein R 1 , L 1 , and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.

First claim

Opening claim text (preview).

The invention claimed is: 1. A temozolomide compound of structure (I) wherein X is —O— or —NH—; n is 1; L 1 is a divalent C 1-6 alkylene group; and R 1 is a methacrylate group, a methacrylamide group, an acrylate group, or an acrylamide group. 2. A temozolomide compound of structure (I) wherein X is —O— or —NH—; n is 1; L 1 is a divalent di(C 2-6 alkylene) disulfide group; and R 1 is a methacrylate group. 3. A temozolomide compound of structure (I) wherein X is —O— or —NH—; n is 1; L 1 is a divalent C 1-6 alkylene group; and R 1 is a methacrylamide group.

Assignees

Inventors

Classifications

  • phenolic · CPC title

  • Esters · CPC title

  • Heterocyclic compounds (A61K47/558 takes precedence) · CPC title

  • Polymers modified by chemical after-treatment · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10562901B2 cover?
A temozolomide compound according to formula (I) is described, wherein R 1 , L 1 , and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
Who is the assignee on this patent?
Univ Massachusetts
What technology area does this patent fall under?
Primary CPC classification C07D487/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).